Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Freve Jonathan
Chief Financial Officer at Damora Therapeutics. Filing since 23 Jun 2021.
CIK 0001664466
Company
Date
Role
Action
Shares
Amount
Of holding
DMRA
Damora Therapeutics, Inc.
3 Dec 2021
Chief Financial Officer
Bought
4,000
$9.96K
50.0%
DMRA
Damora Therapeutics, Inc.
8 Nov 2021
Chief Financial Officer
Bought
3,000
$10.20K
60.0%
DMRA
Damora Therapeutics, Inc.
18 Aug 2021
Chief Financial Officer
Bought
3,000
$11.76K
150%
DMRA
Damora Therapeutics, Inc.
23 Jun 2021
Chief Financial Officer
Bought
2,000
$9.48K
opened
4 decisions on file.
